AUG 17, 2020 3:18 PM PDT

Nervous Protein Neuromedin B May Prevent Immune Reactivity

WRITTEN BY: Kara Marker

A protein produced by the nervous system seems to play a role in regulating the immune system. For people with inflammatory disorders characterized by an unruly immune response, this discovery could mean new, innovative treatments.

The immune system has mechanisms in place to launch the immune response at the right time and cut off inflammation once a threat is cleared. However, inflammation sometimes continues unnecessarily or even initiates unprovoked, leading to common inflammatory diseases like asthma, allergies, chronic fibrosis, and chronic obstructive pulmonary disease (COPD).

Regulatory T cells in the immune system have been known to play a fundamental role in regulating the immune response, but new research points to the nervous system as an additional partner in keeping the balance.

In a recent Nature Immunology study, researchers found that nervous system protein neuromedin B (NMB) is involved in regulating the inflammatory response. NMB has been studied in both the central nervous system (CNS) and the gastrointestinal (GI) tract, and its activity is associated with a wide variety of physiological processes in the body, including: “regulation of exocrine and endocrine secretions, smooth muscle contract, feeding, blood pressure, blood glucose, body temperature, and cell growth.”

In the study, researchers studied the ability of basophils of the immune system to “prime” other immune cells to work with the nervous system to promote NMB receptor expression on the surface of immune cells to support a healthy inflammatory process. Basophils are relatively rare in the body compared to similar immune cells; discovered in 1879, basophils are known to be involved in regulating cytokine-mediated inflammation.

Researchers found that together, basophils and NMBs are associated with reduced inflammation, especially the type of inflammation observed in diseases like asthma, allergies, chronic fibrosis, and COPD.

"For many years, the mechanism through which the body shuts down an inflammatory response to heal itself after worm infections remained poorly understood," explained lead author Mark C. Siracusa. "Our study provided that understanding and a hope for possible treatments using NMB, which has great potential to treat inflammatory diseases like asthma, allergies and COPD."

Sources: Rutgers University, Nature Immunology, The Journal of Allergy and Clinical Immunology, Progress Neurobiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 14, 2020
Microbiology
Seasonal Flu Vaccine Immunity Probably Wears Off
AUG 14, 2020
Seasonal Flu Vaccine Immunity Probably Wears Off
From year to year, the influenza virus mutates and swaps genes with other flu viruses, and we need a new vaccine. But th ...
SEP 07, 2020
Immunology
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
SEP 07, 2020
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
The ability to edit the human genome using CRISPR has been heralded as a revolution in medicine. However, one of the big ...
SEP 21, 2020
Immunology
The Perfect Storm: Wildfires, Flu and COVID-19
SEP 21, 2020
The Perfect Storm: Wildfires, Flu and COVID-19
Over 85 massive wildfires have swept through the West Coast, devastating communities in Washington, Oregon, and Californ ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
Loading Comments...